Cleared Traditional

K800107 - FOLLICLE STIMULATING HORMONE

K800107 is the FDA 510(k) clearance for FOLLICLE STIMULATING HORMONE by Radioimmunoassay, Inc.. It is a Class 1 Chemistry device (product code CGJ) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K800107 · Radioimmunoassay, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1980
Decision
28d
Days
Class 1
Risk

K800107 is an FDA 510(k) clearance for the FOLLICLE STIMULATING HORMONE. Classified as Radioimmunoassay, Follicle-stimulating Hormone (product code CGJ), Class I - General Controls.

Submitted by Radioimmunoassay, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 13, 1980 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1300 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Radioimmunoassay, Inc. devices

Submission Details

510(k) Number K800107 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 16, 1980
Decision Date February 13, 1980
Days to Decision 28 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 88d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CGJ Radioimmunoassay, Follicle-stimulating Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1300
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CGJ Radioimmunoassay, Follicle-stimulating Hormone

All 55
Devices cleared under the same product code (CGJ) and FDA review panel - the closest regulatory comparables to K800107.
LEECO FSH-QUANT DIAGNOSTIC KIT
K810663 · Leeco Diagnostics, Inc. · Mar 1981
HTSH RIABEAD DIAGNOSTIC KIT
K810381 · Abbott Laboratories · Feb 1981
FOLLICE STIMULATING HORMONE-RADIOIMM. KT
K803279 · Immuno Nuclear Corp. · Jan 1981
CENTRIA FSH RIA
K792233 · Union Carbide Corp. · Jan 1980
QUANTIMUNE HFSH RIA
K791836 · Bio-Rad · Oct 1979
RIA SYSTEM FOR HUMAN F-S HORMONE
K780870 · Calbiochem-Behring Corp. · Jun 1978